Effect of C-reactive protein on Fcgamma receptor II in cultured bovine endothelial cells

Clinical Science
Marta Escribano-BurgosJuan Carlos Porres Cubero

Abstract

The major CRP (C-reactive protein) receptor on leucocytes has been identified as the low-affinity IgG receptor Fcgamma receptor II (CD32). Our aim was to assess whether inflammation may modify the presence of the CD32 receptor in BAEC (bovine aortic endothelial cells). Confocal microscopy experiments showed a weak expression of the CD32 receptor in control BAEC that was slightly increased by 10 microg/ml CRP. Incubation of BAEC with TNF-alpha (tumour necrosis factor-alpha) did not modify the fluorescence signal of CD32. Addition of CRP to TNF-alpha-incubated BAEC enhanced the fluorescence signal of the CD32 receptors. The CD32 receptors showed a perinuclear cytoplasmic localization in BAEC. An alteration of the NO (nitric oxide)-dependent vasorelaxation has been defined as endothelial dysfunction. Endothelial dysfunction has been associated with the presence of superoxide anion and with a reduction in the expression of the eNOS (endothelial NO synthase). A concentration of CRP similar to that detected in patients with cardiovascular risk (10 microg/ml) failed to modify the generation of superoxide anion stimulated by TNF-alpha. Western blot experiments showed that TNF-alpha decreased the expression of the eNOS protein, which wa...Continue Reading

References

Aug 18, 1994·The New England Journal of Medicine·G LiuzzoA Maseri
Jun 1, 1993·Molecular Immunology·Y G AlevyT Mohanakumar
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Aug 17, 1999·The Journal of Experimental Medicine·D BharadwajT W Du Clos
Sep 9, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M TorzewskiJ Torzewski
Mar 1, 2002·Journal of the American College of Cardiology·Lourdes Sánchez de MiguelAntonio López-Farré
Sep 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Silvana VielmaMaria Lopes-Virella
May 2, 2003·Current Hypertension Reports·Stefan John, Roland E Schmieder
May 23, 2003·Journal of the American Society of Nephrology : JASN·Elise CourtoisAntonio López-Farré

❮ Previous
Next ❯

Citations

May 24, 2005·Zeitschrift für Rheumatologie·F MoritzH Häntzschel
May 29, 2007·Life Sciences·Peter G NazarovAlexander A Butyugov
Apr 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Sridevi DevarajIshwarlal Jialal
Feb 23, 2008·Annals of Medicine·Sanjay K SinghAlok Agrawal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.